세계의 세포 분리 기술 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

The global demand for Cell Separation Technologies Market is presumed to reach the market size of nearly USD 21.11 Billion by 2032 from USD 8.45 Billion in 2023 with a CAGR of 10.71%.

Cell separation technologies are methods and devices that isolate specific cell types from intricate biological samples, such as blood, tissue, or cell cultures. These technologies rely on physical, biochemical, or immunological principles to selectively capture, separate, and purify target cells based on their unique properties, such as size, density, surface markers, or affinity for specific molecules. Common cell separation techniques include centrifugation, filtration, fluorescence-activated cell sorting (FACS), magnetic-activated cell sorting (MACS), and microfluidic-based sorting. These technologies are essential in biomedical research, diagnostics, and therapeutic applications, enabling the isolation and analysis of rare cell populations with high purity and efficiency.

MARKET DYNAMICS

The factors driving the cell separation technologies market include advancements in biotechnology research, increasing demand for cell-based therapies, and the growing prevalence of chronic diseases. Moreover, the expanding pipeline of cell-based therapies, including CAR-T cell therapies and cell-based vaccines, drives the demand for innovative cell separation methods that enable efficient and scalable production of therapeutic cells. Additionally, the rise of personalized medicine and precision oncology fuels the need for precise and reliable cell separation techniques for molecular diagnostics and targeted therapies. Furthermore, the growing investments in biopharmaceutical R&D and government initiatives supporting regenerative medicine research drive innovation and cell separation technologies market growth. The increasing adoption of automated and high-throughput cell separation platforms also influences the market, enhancing workflow efficiency and reproducibility in research and clinical laboratories. However, technological complexity and high implementation costs may hinder cell separation technologies market growth in the next few years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Cell Separation Technologies. The growth and trends of Cell Separation Technologies industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Cell Separation Technologies market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Instruments
• Consumables & Reagents

By Technology

• Gradient Centrifugation
• Surface Markers Separation
• Fluorescence Activated Cell Sorting
• Magnetic Cell Sorting
• Filtration Based Separation

By Application

• Stem Cell research
• Immunology
• Neuroscience
• Cancer Research
• Others (diagnostics, etc)

By End-user

• Biotechnology & Pharmaceutical Companies
• Hospitals & Diagnostic Laboratories
• Academic & Research Institutes
• Others (CROs, etc)

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Cell Separation Technologies market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cell Separation Technologies market include Akadeum Life Sciences, Stemcell Technologies, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Becton, Dickinson, and Company, Corning Incorporated, Cellenion, Miltenyi Biotec, 10X Genomic, Zeiss, Cytena GmbH, PerkinElmer Inc., Alfa Laval, pluriSelect Life Science UG, PerfuseCell A/S. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . CELL SEPARATION TECHNOLOGIES - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Technology
  • 3.7.3 Market Attractiveness Analysis By Application
  • 3.7.4 Market Attractiveness Analysis By End-user
  • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CELL SEPARATION TECHNOLOGIES MARKET ANALYSIS BY PRODUCT

• 5.1 Overview by Product
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Product
• 5.4 Instruments Historic and Forecast Sales by Regions
• 5.5 Consumables & Reagents Historic and Forecast Sales by Regions

6 . GLOBAL CELL SEPARATION TECHNOLOGIES MARKET ANALYSIS BY TECHNOLOGY

• 6.1 Overview by Technology
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Technology
• 6.4 Gradient Centrifugation Historic and Forecast Sales by Regions
• 6.5 Surface Markers Separation Historic and Forecast Sales by Regions
• 6.6 Fluorescence Activated Cell Sorting Historic and Forecast Sales by Regions
• 6.7 Magnetic Cell Sorting Historic and Forecast Sales by Regions
• 6.8 Filtration Based Separation Historic and Forecast Sales by Regions

7 . GLOBAL CELL SEPARATION TECHNOLOGIES MARKET ANALYSIS BY APPLICATION

• 7.1 Overview by Application
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Application
• 7.4 Stem Cell research Historic and Forecast Sales by Regions
• 7.5 Immunology Historic and Forecast Sales by Regions
• 7.6 Neuroscience Historic and Forecast Sales by Regions
• 7.7 Cancer Research Historic and Forecast Sales by Regions
• 7.8 Others (diagnostics, etc) Historic and Forecast Sales by Regions

8 . GLOBAL CELL SEPARATION TECHNOLOGIES MARKET ANALYSIS BY END-USER

• 8.1 Overview by End-user
• 8.2 Historical and Forecast Data
• 8.3 Analysis by End-user
• 8.4 Biotechnology & Pharmaceutical Companies Historic and Forecast Sales by Regions
• 8.5 Hospitals & Diagnostic Laboratories Historic and Forecast Sales by Regions
• 8.6 Academic & Research Institutes Historic and Forecast Sales by Regions
• 8.7 Others (CROs, etc) Historic and Forecast Sales by Regions

9 . GLOBAL CELL SEPARATION TECHNOLOGIES MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook
• 9.2. Introduction
• 9.3. North America Sales Analysis
  • 9.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.3.2. North America By Segment Sales Analysis
  • 9.3.3. North America By Country Sales Analysis
  • 9.3.4. United State Sales Analysis
  • 9.3.5. Canada Sales Analysis
  • 9.3.6. Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.4.2. Europe by Segment Sales Analysis
  • 9.4.3. Europe by Country Sales Analysis
  • 9.4.4. United Kingdom Sales Analysis
  • 9.4.5. France Sales Analysis
  • 9.4.6. Germany Sales Analysis
  • 9.4.7. Italy Sales Analysis
  • 9.4.8. Russia Sales Analysis
  • 9.4.9. Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.5.2. Asia Pacific by Segment Sales Analysis
  • 9.5.3. Asia Pacific by Country Sales Analysis
  • 9.5.4. China Sales Analysis
  • 9.5.5. India Sales Analysis
  • 9.5.6. Japan Sales Analysis
  • 9.5.7. South Korea Sales Analysis
  • 9.5.8. Australia Sales Analysis
  • 9.5.9. South East Asia Sales Analysis
  • 9.5.10. Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.6.2. Latin America by Segment Sales Analysis
  • 9.6.3. Latin America by Country Sales Analysis
  • 9.6.4. Brazil Sales Analysis
  • 9.6.5. Argentina Sales Analysis
  • 9.6.6. Peru Sales Analysis
  • 9.6.7. Chile Sales Analysis
  • 9.6.8. Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.7.2. Middle East & Africa by Segment Sales Analysis
  • 9.7.3. Middle East & Africa by Country Sales Analysis
  • 9.7.4. Saudi Arabia Sales Analysis
  • 9.7.5. UAE Sales Analysis
  • 9.7.6. Israel Sales Analysis
  • 9.7.7. South Africa Sales Analysis
  • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE CELL SEPARATION TECHNOLOGIES COMPANIES

• 10.1. Cell Separation Technologies Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11 . COMPANY PROFILES OF CELL SEPARATION TECHNOLOGIES INDUSTRY

• 11.1. Company Share Analysis
• 11.2. Market Concentration Rate
• 11.3. Akadeum Life Sciences
  • 11.3.1. Company Overview
  • 11.3.2. Company Revenue
  • 11.3.3. Products
  • 11.3.4. Recent Developments
• 11.4. Stemcell Technologies
  • 11.4.1. Company Overview
  • 11.4.2. Company Revenue
  • 11.4.3. Products
  • 11.4.4. Recent Developments
• 11.5. Bio-Rad Laboratories Inc.
  • 11.5.1. Company Overview
  • 11.5.2. Company Revenue
  • 11.5.3. Products
  • 11.5.4. Recent Developments
• 11.6. Thermo Fisher Scientific Inc.
  • 11.6.1. Company Overview
  • 11.6.2. Company Revenue
  • 11.6.3. Products
  • 11.6.4. Recent Developments
• 11.7. Becton
  • 11.7.1. Company Overview
  • 11.7.2. Company Revenue
  • 11.7.3. Products
  • 11.7.4. Recent Developments
• 11.8. Dickinson and Company
  • 11.8.1. Company Overview
  • 11.8.2. Company Revenue
  • 11.8.3. Products
  • 11.8.4. Recent Developments
• 11.9. Corning Incorporated
  • 11.9.1. Company Overview
  • 11.9.2. Company Revenue
  • 11.9.3. Products
  • 11.9.4. Recent Developments
• 11.10. Cellenion
  • 11.10.1. Company Overview
  • 11.10.2. Company Revenue
  • 11.10.3. Products
  • 11.10.4. Recent Developments
• 11.11. Miltenyi Biotec
  • 11.11.1. Company Overview
  • 11.11.2. Company Revenue
  • 11.11.3. Products
  • 11.11.4. Recent Developments
• 11.12. 10X Genomic
  • 11.12.1. Company Overview
  • 11.12.2. Company Revenue
  • 11.12.3. Products
  • 11.12.4. Recent Developments
• 11.13. Zeiss
  • 11.13.1. Company Overview
  • 11.13.2. Company Revenue
  • 11.13.3. Products
  • 11.13.4. Recent Developments
• 11.14. Cytena GmbH
  • 11.14.1. Company Overview
  • 11.14.2. Company Revenue
  • 11.14.3. Products
  • 11.14.4. Recent Developments
• 11.15. PerkinElmer Inc.
  • 11.15.1. Company Overview
  • 11.15.2. Company Revenue
  • 11.15.3. Products
  • 11.15.4. Recent Developments
• 11.16. Alfa Laval
  • 11.16.1. Company Overview
  • 11.16.2. Company Revenue
  • 11.16.3. Products
  • 11.16.4. Recent Developments
• 11.17. pluriSelect Life Science UG
  • 11.17.1. Company Overview
  • 11.17.2. Company Revenue
  • 11.17.3. Products
  • 11.17.4. Recent Developments
• 11.18. PerfuseCell A/S.
  • 11.18.1. Company Overview
  • 11.18.2. Company Revenue
  • 11.18.3. Products
  • 11.18.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies